The European Union must also contend with a constantly evolving market and socio-economic fabric, revising its objectives and directives in light of these transformations.
The project is born out of a concrete demand within the pharma supply chain to provide a hi-tech solution to tackle the problem of limited-supply and out-of-stock medicine.